EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C23H28F2N6O4S |
| Net Charge | 0 |
| Average Mass | 522.578 |
| Monoisotopic Mass | 522.18608 |
| SMILES | CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1 |
| InChI | InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1 |
| InChIKey | OEKWJQXRCDYSHL-FNOIDJSQSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. P2Y12 receptor antagonist An antagonist at the P2Y12 receptor antiviral agent A substance that destroys or inhibits replication of viruses. |
| Applications: | anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. anticoagulant An agent that prevents blood clotting. hypoglycemic agent A drug which lowers the blood glucose level. anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. renoprotective agent Any compound that is able to prevent damage to the kidneys. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. platelet aggregation inhibitor A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ticagrelor (CHEBI:68558) has role anti-anaemic agent (CHEBI:75835) |
| ticagrelor (CHEBI:68558) has role anti-arrhythmia drug (CHEBI:38070) |
| ticagrelor (CHEBI:68558) has role anticoagulant (CHEBI:50249) |
| ticagrelor (CHEBI:68558) has role antimicrobial agent (CHEBI:33281) |
| ticagrelor (CHEBI:68558) has role antiviral agent (CHEBI:22587) |
| ticagrelor (CHEBI:68558) has role cardiovascular drug (CHEBI:35554) |
| ticagrelor (CHEBI:68558) has role hypoglycemic agent (CHEBI:35526) |
| ticagrelor (CHEBI:68558) has role P2Y12 receptor antagonist (CHEBI:68563) |
| ticagrelor (CHEBI:68558) has role platelet aggregation inhibitor (CHEBI:50427) |
| ticagrelor (CHEBI:68558) has role renoprotective agent (CHEBI:231911) |
| ticagrelor (CHEBI:68558) is a aryl sulfide (CHEBI:35683) |
| ticagrelor (CHEBI:68558) is a hydroxyether (CHEBI:46789) |
| ticagrelor (CHEBI:68558) is a organofluorine compound (CHEBI:37143) |
| ticagrelor (CHEBI:68558) is a secondary amino compound (CHEBI:50995) |
| ticagrelor (CHEBI:68558) is a triazolopyrimidines (CHEBI:48435) |
| IUPAC Name |
|---|
| (1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| INN | Source |
|---|---|
| ticagrelor | KEGG DRUG |
| Synonyms | Source |
|---|---|
| (1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol | ChemIDplus |
| AR-C126532XX | ChEMBL |
| AZD 6140 | ChemIDplus |
| AZD-6140 | ChemIDplus |
| AZD6140 | ChemIDplus |
| Brand Name | Source |
|---|---|
| Brilinta | KEGG DRUG |
| Manual Xrefs | Databases |
|---|---|
| 4184 | DrugCentral |
| D09017 | KEGG DRUG |
| HMDB0015702 | HMDB |
| WO2012085665 | Patent |
| Registry Numbers | Sources |
|---|---|
| Reaxys:15468079 | Reaxys |
| CAS:274693-27-5 | ChemIDplus |
| Citations |
|---|